| scholarly article | Q13442814 |
| P50 | author | Xun Jin | Q57020388 |
| P2093 | author name string | Do-Hyun Nam | |
| Sung-Hak Kim | |||
| Yun-Jaie Choi | |||
| Hyunggee Kim | |||
| Jinlong Yin | |||
| Samuel Beck | |||
| Sung-Chan Kim | |||
| Jun-Kyum Kim | |||
| Young-Woo Sohn | |||
| Xumin Pian | |||
| P2860 | cites work | Telomerase modulates expression of growth-controlling genes and enhances cell proliferation | Q73322990 |
| TERT regulates cell survival independent of telomerase enzymatic activity | Q74355604 | ||
| Telomerase and telomere length in the development and progression of premalignant lesions to colorectal cancer | Q77553578 | ||
| Telomerase modulates Wnt signalling by association with target gene chromatin | Q24310084 | ||
| A distinct "side population" of cells with high drug efflux capacity in human tumor cells | Q24564100 | ||
| Comprehensive genomic characterization defines human glioblastoma genes and core pathways | Q24656128 | ||
| Glioma stem cells promote radioresistance by preferential activation of the DNA damage response | Q27860541 | ||
| Identification of human brain tumour initiating cells | Q27860921 | ||
| Tumor stem cells derived from glioblastomas cultured in bFGF and EGF more closely mirror the phenotype and genotype of primary tumors than do serum-cultured cell lines | Q29615823 | ||
| Expression of telomere-associated genes as prognostic markers for overall survival in patients with non-small cell lung cancer. | Q33259358 | ||
| TERT promotes epithelial proliferation through transcriptional control of a Myc- and Wnt-related developmental program | Q33315569 | ||
| Functional multimerization of the human telomerase reverse transcriptase | Q33969441 | ||
| Human telomerase catalytic subunit (hTERT) suppresses p53-mediated anti-apoptotic response via induction of basic fibroblast growth factor. | Q34086792 | ||
| Gliomagenesis: genetic alterations and mouse models | Q34186001 | ||
| Telomerase contributes to tumorigenesis by a telomere length-independent mechanism | Q34188701 | ||
| Human telomere reverse transcriptase expression predicts progression and survival in pediatric intracranial ependymoma | Q34507174 | ||
| Brain tumour stem cells | Q36488721 | ||
| Telomerase therapeutics for cancer: challenges and new directions | Q36506309 | ||
| Inhibitor of differentiation 4 drives brain tumor-initiating cell genesis through cyclin E and notch signaling | Q36802989 | ||
| Biology of glioma cancer stem cells | Q37572450 | ||
| Glioma stem cell lines expanded in adherent culture have tumor-specific phenotypes and are suitable for chemical and genetic screens | Q39842716 | ||
| Isolation and characterization of cancer stem like cells in human glioblastoma cell lines | Q39881450 | ||
| hTERT antagonizes p53-induced apoptosis independently of telomerase activity. | Q40479122 | ||
| Telomere changes in human hepatocellular carcinomas and hepatitis virus infected noncancerous livers | Q45771270 | ||
| TERT promotes cellular and organismal survival independently of telomerase activity | Q46788573 | ||
| Telomere shortening in gastric carcinoma with aging despite telomerase activation | Q50664218 | ||
| Clinical and biological implications of CD133-positive and CD133-negative cells in glioblastomas | Q53471082 | ||
| P433 | issue | 1 | |
| P921 | main subject | neoplastic stem cells | Q1638475 |
| P304 | page(s) | 9-15 | |
| P577 | publication date | 2010-12-24 | |
| P1433 | published in | Molecules and Cells | Q12623193 |
| P1476 | title | Telomerase activity-independent function of TERT allows glioma cells to attain cancer stem cell characteristics by inducing EGFR expression | |
| P478 | volume | 31 |
| Q64898796 | A Role for NF-κB in Organ Specific Cancer and Cancer Stem Cells. |
| Q39294110 | Alternatively Spliced Telomerase Reverse Transcriptase Variants Lacking Telomerase Activity Stimulate Cell Proliferation |
| Q35644577 | Association of TERT Polymorphisms with Clinical Outcome of Non-Small Cell Lung Cancer Patients |
| Q36562573 | Biological and clinical implications of cancer stem cells in primary brain tumors |
| Q38861997 | DNA methylation in adult diffuse gliomas |
| Q26853549 | EGFR Amplification and Glioblastoma Stem-Like Cells |
| Q47236669 | Fine‐mapping of a region of chromosome 5p15.33 (TERT‐CLPTM1L) suggests a novel locus in TERT and a CLPTM1L haplotype are associated with glioma susceptibility in a Chinese population |
| Q39165033 | FoxG1 interacts with Bmi1 to regulate self-renewal and tumorigenicity of medulloblastoma stem cells |
| Q38016280 | Glioblastoma cancer stem cells – From concept to clinical application |
| Q47118202 | Human glioma stem-like cells induce malignant transformation of bone marrow mesenchymal stem cells by activating TERT expression |
| Q33890901 | Medaka tert produces multiple variants with differential expression during differentiation in vitro and in vivo |
| Q49442455 | Preclinical and clinical implications of TERT promoter mutation in glioblastoma multiforme |
| Q36959186 | Primary breast cancer stem-like cells metastasise to bone, switch phenotype and acquire a bone tropism signature. |
| Q38793244 | Progression inference for somatic mutations in cancer |
| Q37325708 | R-Spondin 1 promotes vibration-induced bone formation in mouse models of osteoporosis |
| Q90749197 | TERT, a promoter of CNS malignancies |
| Q37395716 | Telomerase reverse transcriptase promotes cancer cell proliferation by augmenting tRNA expression |
| Q37093504 | Telomerase reverse transcriptase promotes the proliferation of human laryngeal carcinoma cells through activation of the activator protein 1 |
| Q45151770 | Telomerase: central regulator of all of the hallmarks of cancer |
| Q26744808 | Telomere and Telomerase Therapeutics in Cancer |
| Q39413214 | Telomeres and telomerase in prostate cancer development and therapy. |
| Q35009536 | The human melanoma side population displays molecular and functional characteristics of enriched chemoresistance and tumorigenesis |
| Q27027457 | Therapeutic targeting of replicative immortality |
| Q52662392 | When the Ends Are Really the Beginnings: Targeting Telomerase for Treatment of GBM. |
Search more.